- Home
- CPBI vs ADAP Comparison
CPBI vs ADAP Comparison
Compare CPBI & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- ADAP
- Stock Information
- Founded
- CPBI 2023
- ADAP 2008
- Country
- CPBI United States
- ADAP United Kingdom
- Employees
- CPBI N/A
- ADAP N/A
- Industry
- CPBI
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- ADAP Health Care
- Exchange
- CPBI Nasdaq
- ADAP Nasdaq
- Market Cap
- CPBI 63.0M
- ADAP 75.5M
- IPO Year
- CPBI N/A
- ADAP 2015
- Fundamental
- Price
- CPBI $14.99
- ADAP $0.35
- Analyst Decision
- CPBI
- ADAP Buy
- Analyst Count
- CPBI 0
- ADAP 6
- Target Price
- CPBI N/A
- ADAP $1.35
- AVG Volume (30 Days)
- CPBI 1.4K
- ADAP 745.6K
- Earning Date
- CPBI 01-01-0001
- ADAP 08-11-2025
- Dividend Yield
- CPBI N/A
- ADAP N/A
- EPS Growth
- CPBI N/A
- ADAP N/A
- EPS
- CPBI 0.96
- ADAP N/A
- Revenue
- CPBI $18,899,000.00
- ADAP $179,639,000.00
- Revenue This Year
- CPBI N/A
- ADAP N/A
- Revenue Next Year
- CPBI N/A
- ADAP $37.22
- P/E Ratio
- CPBI $15.65
- ADAP N/A
- Revenue Growth
- CPBI 9.64
- ADAP 878.53
- 52 Week Low
- CPBI $10.69
- ADAP $0.20
- 52 Week High
- CPBI $15.50
- ADAP $1.48
- Technical
- Relative Strength Index (RSI)
- CPBI 52.98
- ADAP 75.18
- Support Level
- CPBI $14.86
- ADAP $0.27
- Resistance Level
- CPBI $15.20
- ADAP $0.36
- Average True Range (ATR)
- CPBI 0.06
- ADAP 0.02
- MACD
- CPBI -0.00
- ADAP 0.01
- Stochastic Oscillator
- CPBI 40.00
- ADAP 90.51
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.